Ameriprise’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $54.9M | Sell |
|
|||||
2025
Q1 | $54.6M | Sell |
|
|||||
2024
Q4 | $56.1M | Sell |
|
|||||
2024
Q3 | $138M | Sell |
|
|||||
2024
Q2 | $296M | Buy |
|
|||||
2024
Q1 | $236M | Buy |
|
|||||
2023
Q4 | $141M | Buy |
|
|||||
2023
Q3 | $115M | Sell |
|
|||||
2023
Q2 | $198M | Sell |
|
|||||
2023
Q1 | $182M | Buy |
|
|||||
2022
Q4 | $163M | Sell |
|
|||||
2022
Q3 | $283M | Sell |
|
|||||
2022
Q2 | $365M | Buy |
|
|||||
2022
Q1 | $348M | Buy |
|
|||||
2021
Q4 | $355M | Sell |
|
|||||
2021
Q3 | $374M | Sell |
|
|||||
2021
Q2 | $524M | Buy |
|
|||||
2021
Q1 | $421M | Buy |
|
|||||
2020
Q4 | $333M | Sell |
|
|||||
2020
Q3 | $305M | Sell |
|
|||||
2020
Q2 | $270M | Buy |
|
|||||
2020
Q1 | $219M | Sell |
|
|||||
2019
Q4 | $357M | Sell |
|
|||||
2019
Q3 | $370M | Sell |
|
|||||
2019
Q2 | $347M | Sell |
|
|||||
2019
Q1 | $367M | Sell |
|
|||||
2018
Q4 | $334M | Sell |
|
|||||
2018
Q3 | $390M | Sell |
|
|||||
2018
Q2 | $340M | Sell |
|
|||||
2018
Q1 | $406M | Sell |
|
|||||
2017
Q4 | $428M | Sell |
|
|||||
2017
Q3 | $463M | Sell |
|
|||||
2017
Q2 | $515M | Sell |
|
|||||
2017
Q1 | $540M | Buy |
|
|||||
2016
Q4 | $458M | Buy |
|
|||||
2016
Q3 | $521M | Buy |
|
|||||
2016
Q2 | $424M | Buy |
|
|||||
2016
Q1 | $231M | Buy |
|
|||||
2015
Q4 | $24.3M | Sell |
|
|||||
2015
Q3 | $23.2M | Buy |
|
|||||
2015
Q2 | $7.63M | Buy |
|
|||||
2015
Q1 | $6.53M | Sell |
|
|||||
2014
Q4 | $12.5M | Buy |
|
|||||
2014
Q3 | $6.09M | Buy |
|
|||||
2014
Q2 | $3.16M | Sell |
|
|||||
2014
Q1 | $2.75M | Sell |
|
|||||
2013
Q4 | $3.56M | Sell |
|
|||||
2013
Q3 | $4.1M | Sell |
|
|||||
2013
Q2 | $323M | Buy |
|